Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Long-Term Investments (2021 - 2023)

Historic Long-Term Investments for ADC Therapeutics (ADCT) over the last 3 years, with Q3 2023 value amounting to $27.0 million.

  • ADC Therapeutics' Long-Term Investments fell 2219.28% to $27.0 million in Q3 2023 from the same period last year, while for Sep 2023 it was $27.0 million, marking a year-over-year decrease of 2219.28%. This contributed to the annual value of $7.6 million for FY2022, which is 1836202.35% up from last year.
  • Per ADC Therapeutics' latest filing, its Long-Term Investments stood at $27.0 million for Q3 2023, which was down 2219.28% from $28.3 million recorded in Q2 2023.
  • Over the past 5 years, ADC Therapeutics' Long-Term Investments peaked at $47.4 million during Q1 2021, and registered a low of $41236.0 during Q4 2021.
  • Its 3-year average for Long-Term Investments is $30.9 million, with a median of $34.7 million in 2022.
  • In the last 5 years, ADC Therapeutics' Long-Term Investments surged by 1836202.35% in 2022 and then tumbled by 2375.43% in 2023.
  • Quarter analysis of 3 years shows ADC Therapeutics' Long-Term Investments stood at $41236.0 in 2021, then surged by 18362.02% to $7.6 million in 2022, then soared by 254.51% to $27.0 million in 2023.
  • Its last three reported values are $27.0 million in Q3 2023, $28.3 million for Q2 2023, and $29.5 million during Q1 2023.